Complete Genomics GNOM DNA analysis for human genome Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Complete Genomics GNOM DNA analysis for human genome

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: Maurice Winn who wrote (7)	9/16/2011 7:48:28 AM
From: idos	Read Replies (1) of 45

>There are 6,000,000,000 people so there's a lot of demand at the right price< If you take a look at GNOM's costumers list you won't find 'people' there, rather the research community - big academic centers, institutions, and agencies. GNOM is focused on whole genome sequencing services and it is not alone. ILMN has it's own service network and is competing on price for large projects and BGI is another player that cannot be ignored. Agree about your point that when the price is low enough, demand will increase but at current price and budgets cut, impact to GNOM might be negative near term. >once the price is right, then medical treatments will probably follow< Potential is there but not likely without having a CLIA certification (ILMN does have one) in a year or so.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next